# Georgia Eye Bank, Inc. – FDA Inspection, May 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/georgia-eye-bank-inc/ad7a4b7b-d888-4124-b02f-3ff42160ddee
Source feed: FDA_Inspections

> FDA inspection 1090641 of Georgia Eye Bank, Inc., May 24, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1090641
- Company Name: Georgia Eye Bank, Inc.
- Inspection Date: 2019-05-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1314808 - 2026-04-30](https://www.keypedia.com/records/fda_inspections/georgia-eye-bank-inc/6c762128-4a3a-4c7f-9746-3d5d4e7dd2b6)
- FDA Inspection 1192021 - 2022-11-08
- FDA Inspection 1028414 - 2017-09-28
- FDA Inspection 938757 - 2015-08-19
- FDA Inspection 829797 - 2013-05-01

## Related Officers

- [Company Rep](https://www.keypedia.com/people/leslie-w-gilbert/5c8b9e87-9563-4403-89ad-cfa3282a1ba5)

Company: https://www.keypedia.com/companies/georgia-eye-bank-inc/6fb2513a-c7e5-4957-9e38-fea6c411fb9a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
